Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Podzamczer

Showing results (11-20 of 181) with videos related to

Pageof 19
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|August 14, 2010
Maraviroc concentrations in cerebrospinal fluid in HIV-infected patientsJuan Manuel Tiraboschi, Jordi Niubo, Jordi Curto, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|February 2, 2010
[Etravirine in highly treatment-experienced patients]Daniel Podzamczer Palter, Elena Ferrer Corbera, Juan Manuel Tiraboschi
The American Journal of Tropical Medicine and Hygiene|July 3, 2010
Visceral Leishmaniasis treated with antimonials/paromomycin followed by itraconazole/miltefosine after standard therapy failures in a human immunodeficiency virus-infected patientPatricia Barragán, Rogelio López-Velez, Montserrat Olmo, et al.
Personalized Medicine|February 27, 2013
Clinical perspectives on human genetic screening to prevent nevirapine toxicityDavid W Haas, Piroon Mootsikapun, Kiat Ruxrungtham, et al.
Journal of Clinical Medicine|August 27, 2021
Do All Integrase Strand Transfer Inhibitors Have the Same Lipid Profile? Review of Randomised Controlled Trials in Naïve and Switch Scenarios in HIV-Infected PatientsMaria Saumoy, Jose Luís Sanchez-Quesada, Jordi Ordoñez-Llanos, et al.
Medicina Clinica|July 26, 2017
Extracutaneous atypical syphilis in HIV-infected patientsPaula Prieto, Arkaitz Imaz, Laura Calatayud, et al.
HIV Research & Clinical Practice|February 18, 2020
Long-term efficacy and safety of nevirapine-containing regimens in virologically suppressed patients: a 17-year follow upJuan Tiraboschi, Natalia Lattour, Hernando Knobel, et al.
Antiviral Therapy|February 2, 2012
Fatal bacillary angiomatosis mimicking an infiltrative vascular tumour in the immune restoration phase of an HIV-infected patientOscar Murillo, Daniel Mimbrera, Ana Petit, et al.
AIDS Reviews|September 16, 2010
Community associated methicillin-resistant Staphylococcus aureus in HIV-infected patientsArkaitz Imaz, Miquel Pujol, Patricia Barragán, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
A comparison of the effects of nevirapine and nelfinavir on metabolism and body habitus in antiretroviral-naive human immunodeficiency virus-infected patients: a randomized controlled studyCesar Fisac, Nuria Virgili, Elena Ferrer, et al.
Pageof 19

Showing results (11-20 of 181) with videos related to

Sort By:
Pageof 19
Journal of Acquired Immune Deficiency Syndromes (1999)|August 14, 2010
Maraviroc concentrations in cerebrospinal fluid in HIV-infected patientsJuan Manuel Tiraboschi, Jordi Niubo, Jordi Curto, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|February 2, 2010
[Etravirine in highly treatment-experienced patients]Daniel Podzamczer Palter, Elena Ferrer Corbera, Juan Manuel Tiraboschi
The American Journal of Tropical Medicine and Hygiene|July 3, 2010
Visceral Leishmaniasis treated with antimonials/paromomycin followed by itraconazole/miltefosine after standard therapy failures in a human immunodeficiency virus-infected patientPatricia Barragán, Rogelio López-Velez, Montserrat Olmo, et al.
Personalized Medicine|February 27, 2013
Clinical perspectives on human genetic screening to prevent nevirapine toxicityDavid W Haas, Piroon Mootsikapun, Kiat Ruxrungtham, et al.
Journal of Clinical Medicine|August 27, 2021
Do All Integrase Strand Transfer Inhibitors Have the Same Lipid Profile? Review of Randomised Controlled Trials in Naïve and Switch Scenarios in HIV-Infected PatientsMaria Saumoy, Jose Luís Sanchez-Quesada, Jordi Ordoñez-Llanos, et al.
Medicina Clinica|July 26, 2017
Extracutaneous atypical syphilis in HIV-infected patientsPaula Prieto, Arkaitz Imaz, Laura Calatayud, et al.
HIV Research & Clinical Practice|February 18, 2020
Long-term efficacy and safety of nevirapine-containing regimens in virologically suppressed patients: a 17-year follow upJuan Tiraboschi, Natalia Lattour, Hernando Knobel, et al.
Antiviral Therapy|February 2, 2012
Fatal bacillary angiomatosis mimicking an infiltrative vascular tumour in the immune restoration phase of an HIV-infected patientOscar Murillo, Daniel Mimbrera, Ana Petit, et al.
AIDS Reviews|September 16, 2010
Community associated methicillin-resistant Staphylococcus aureus in HIV-infected patientsArkaitz Imaz, Miquel Pujol, Patricia Barragán, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
A comparison of the effects of nevirapine and nelfinavir on metabolism and body habitus in antiretroviral-naive human immunodeficiency virus-infected patients: a randomized controlled studyCesar Fisac, Nuria Virgili, Elena Ferrer, et al.
Pageof 19